About Us Contact Us Disclaimer Sitemap
  New Old
HOME TRADING DERIVATIVES PMS MUTUAL FUNDS IPO BONDS RESEARCH MARKET
left «« +1 «« -1 right
 
  Equity Analysis
  Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
  Volume
  Analysis
  News Analysis
Corporate Action
  Corporate Info
  Other Market
 
Company News  
 
Lupin Ltd.
Change Company   
BSE Code 500257
ISIN Demat INE326A01037
Book Value(Rs.) 382.97
NSE Code LUPIN
Dividend Yield % 0.72
Market Cap(Rs. in millions) 316712.73
P/E 30.31
EPS 23.07
Face Value(Rs.) 2  
17-Feb-2020 USFDA completes inspection of Lupin’s Aurangabad ...
17-Feb-2020 Lupin moves up on launching Moxifloxacin Ophthalm...
17-Feb-2020 Announcement under Regulation 30 (LODR)-Press Re...
14-Feb-2020 Lupin launches Moxifloxacin Ophthalmic Solution
14-Feb-2020 Lupin informs about earnings call transcript
14-Feb-2020 Announcement under Regulation 30 (LODR)-Press Re...
13-Feb-2020 Lupin informs about press release
12-Feb-2020 USFDA completes inspection of Lupin’s Pithampur f...
12-Feb-2020 Announcement under Regulation 30 (LODR)-Press Re...
07-Feb-2020 Lupin informs about investor presentation
06-Feb-2020 Lupin gets nod for Leflunomide Tablets
06-Feb-2020 Lupin shines on getting nod for Leflunomide Table...
06-Feb-2020 Lupin, Panacea Biotec and Avenue Supermarkets to ...
04-Feb-2020 Announcement under Regulation 30 (LODR)-Allotmen...
27-Jan-2020 Announcement under Regulation 30 (LODR)-Press Re...
Page 1 of 7
Prev || Next
 
Terms & Conditions Copyright ©ATLAS All rights reserved. Designed || Developed & Content Powered By Accord Fintech Pvt.Ltd.

Important Links : SEBI | NSE | BSE | RBI | CDSL | NSDL | Investor Grievance| Policy
SEBI REG. NO. NSE : CASH INZ000166836; FO INZ000166836| BSE : CASH INZ000166836; FO INZ000166836
PMS : INP000000530 | AMFI : ARN0770 | CDSL : IN-DP-CDSL-465-2008